Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
$0.00
$0.00
$0.00
$0.00
$240K-1.838.09 million shs1.01 million shs
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
$0.00
$0.17
$0.00
$3.40
$31K-17.745,371 shs330 shs
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
$0.00
$0.00
$0.10
$70K0.7713.46 million shsN/A
MAGAA
Magna-Lab
$0.08
$0.07
$0.11
$2.00
$89K7.513,117 shsN/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
0.00%+100.00%+100.00%0.00%-83.33%
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
0.00%+50.00%-99.85%-99.81%-99.85%
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
0.00%0.00%0.00%0.00%0.00%
MAGAA
Magna-Lab
0.00%+17.76%-1.82%+10.85%-93.06%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
N/AN/AN/AN/AN/AN/AN/AN/A
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
N/AN/AN/AN/AN/AN/AN/AN/A
MAGAA
Magna-Lab
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
0.00
N/AN/AN/A
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
0.00
N/AN/AN/A
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
0.00
N/AN/AN/A
MAGAA
Magna-Lab
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
$10K24.13$0.02 per share0.01($0.08) per share0.00
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
$80K0.39N/AN/A$0.38 per share0.00
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
$21.76M0.00N/AN/AN/ANaN
MAGAA
Magna-Lab
N/AN/AN/AN/A($1.52) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
-$2.80MN/A0.00N/AN/AN/AN/AN/A
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
-$270KN/A0.00N/A-453.55%-6.43%-4.43%N/A
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
-$31.14MN/A0.00N/AN/AN/AN/AN/AN/A
MAGAA
Magna-Lab
-$130K$0.180.42N/AN/A-12.32%42,399.99%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
N/AN/AN/AN/AN/A
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
N/AN/AN/AN/AN/A
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
N/AN/AN/AN/AN/A
MAGAA
Magna-Lab
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
N/AN/AN/A
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
N/A
0.35
0.34
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
N/AN/AN/A
MAGAA
Magna-Lab
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
N/A
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
N/A
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
N/A
MAGAA
Magna-Lab
N/A

Insider Ownership

CompanyInsider Ownership
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
5.61%
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
89.24%
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
19.80%
MAGAA
Magna-Lab
15.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
11.21 billion1.14 billionNot Optionable
Heyu Biological Technology Co. stock logo
HYBT
Heyu Biological Technology
6103.25 million11.11 millionNot Optionable
Item 9 Labs Corp. stock logo
INLB
Item 9 Labs
100701.92 million562.85 millionNot Optionable
MAGAA
Magna-Lab
201.18 millionN/ANot Optionable

Recent News About These Companies

TSX:MG (Magna International Inc.)
Aiken County Public Library events for the month of September
MAGAA/USD - MAGA AGAIN US Dollar
Pathology & Lab Medicine
NATIONAL DAY CALENDAR: Magna Carta Day
Endonovo Therapeutics stock logo

Endonovo Therapeutics OTCMKTS:ENDV

$0.0002 0.00 (0.00%)
As of 01:48 PM Eastern

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

Heyu Biological Technology stock logo

Heyu Biological Technology OTCMKTS:HYBT

$0.0003 0.00 (0.00%)
As of 06/18/2025

Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.

Item 9 Labs stock logo

Item 9 Labs OTC:INLB

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

Magna-Lab OTCMKTS:MAGAA

$0.08 0.00 (0.00%)
As of 06/18/2025

Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. The company was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.